Teresa B. Del Castillo
Oviedo, AS, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
Journal: British journal of haematology
Published: June 28, 2024
Mapping the genetic features of T-ALL cases through simplified NGS approach.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 18, 2022
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Journal: European journal of haematology
Published: October 05, 2021
Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].
Journal: Leukemia research
Published: July 19, 2020
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.
Journal: Leukemia research
Published: November 06, 2019
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care.
Journal: Leukemia
Published: May 28, 2018
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
Journal: BMC cancer
Published: August 22, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026